Conduit Pharmaceuticals Stock Filter Stocks by Fundamentals
| CDT Stock | 2.16 0.06 2.86% |
Conduit Pharmaceuticals' fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Conduit Stock price.
Conduit | Shares Owned by Insiders | Build AI portfolio with Conduit Stock |
Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
Conduit Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Conduit Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Conduit Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Conduit Fundamentals
| Return On Asset | -1.68 | ||||
| Current Valuation | 5.81 M | ||||
| Shares Outstanding | 2.41 M | ||||
| Shares Owned By Insiders | 13.50 % | ||||
| Shares Owned By Institutions | 1.46 % | ||||
| Number Of Shares Shorted | 93.43 K | ||||
| Price To Book | 1.89 X | ||||
| Revenue | 922.22 M | ||||
| EBITDA | 266.46 M | ||||
| Net Income | (17.8 M) | ||||
| Total Debt | 7.46 M | ||||
| Book Value Per Share | 4.24 X | ||||
| Cash Flow From Operations | (9.68 M) | ||||
| Short Ratio | 0.13 X | ||||
| Earnings Per Share | (255.60) X | ||||
| Beta | 1.94 | ||||
| Market Capitalization | 5.05 M | ||||
| Total Asset | 4.19 M | ||||
| Retained Earnings | (29.1 M) | ||||
| Working Capital | (8.03 M) | ||||
| Net Asset | 4.19 M |
About Conduit Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Conduit Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Conduit Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Conduit Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Conduit Stock Analysis
When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.